OPEXA THERAPEUTICS
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of patient-specific immunotherapies for the treatment of multiple sclerosis. The Company’s leading therapy candidate, Tcelna™, is a personalized T-cell immunotherapy in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive Multiple Sclerosis. Opexa’s mission is to lead the field of Precision Immunotherapy™ by aligning the interests of patients, employees and shareholders. Opexa is located in The Woodlands, Texas north of Houston on one acre of forested land and houses its cGMP facility, research laboratories and corporate offices.
OPEXA THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1986-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.opexatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(281) 272-9331
Email Addresses:
[email protected]
Total Funding:
5.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content CPanel SSL One.com DNS SingleHop
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.opexatherapeutics.com
- Host name: cphost23.qhoster.net
- IP address: 104.243.33.214
- Location: Miami United States
- Latitude: 25.8119
- Longitude: -80.2318
- Metro Code: 528
- Timezone: America/New_York
- Postal: 33142
